Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
about
Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trialMultilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice.A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.An educational review of the statistical issues in analysing utility data for cost-utility analysis.Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelingMethods for analyzing cost effectiveness data from cluster randomized trials.Silk garments plus standard care compared with standard care for treating eczema in children: A randomised, controlled, observer-blind, pragmatic trial (CLOTHES Trial).Statistical analysis of cost-effectiveness data from randomized clinical trials.Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.Effectiveness and efficiency of integrated mental health care programmes in Germany: study protocol of an observational controlled trial.A pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocolCost-effectiveness of a rapid response team intervention for suicidal youth presenting at an emergency departmentBayesian variable selection in cost-effectiveness analysis.Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.Average cost-effectiveness ratio with censored dataStatistical methods for cost-effectiveness analyses that use observational data: a critical appraisal tool and review of current practice.Methods for estimating subgroup effects in cost-effectiveness analyses that use observational data.Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.The Impact of Outliers on Net-Benefit Regression Model in Cost-Effectiveness AnalysisCost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial.Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.A participatory supportive return to work program for workers without an employment contract, sick-listed due to a common mental disorder: an economic evaluation alongside a randomized controlled trial.Developing appropriate methods for cost-effectiveness analysis of cluster randomized trialsEuropean COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectivenessWordless intervention for people with epilepsy and learning disabilities (WIELD): a randomised controlled feasibility trial'Health Economics' and the evolution of economic evaluation of health technologies.Statistical considerations in economic evaluations: a guide for cardiologists.Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease.Cost-effectiveness of manual therapy versus physiotherapy in patients with sub-acute and chronic neck pain: a randomised controlled trial.Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.Measurement of total hemoglobin reduces red cell transfusion in hospitalized patients undergoing cardiac surgery: a retrospective database analysis.Subgroup analysis of telehealthcare for patients with chronic obstructive pulmonary disease: the cluster-randomized Danish Telecare North Trial.Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial.Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis.Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials.Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer: Results from the quality of life in motion study.Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
P2860
Q30602872-03B61982-6781-4A19-8AAE-B418E931C31BQ30717228-34F07EE1-24AC-42E5-AEA0-EE8260A8F2F0Q30839137-C21DD69C-4E07-4A4E-A87B-98C399E1A72CQ30884759-48954320-F874-4FB0-96A0-2D3E1789C8DCQ31119280-BC0CFF2D-796B-4D87-AA27-76E97D944962Q31126466-C50E9417-9AA3-47F8-B8BD-CB6683180F64Q33554332-854178FE-F7AA-4106-9B54-C36AB729A2B6Q33596439-13D3BCED-C219-4E1F-AB78-EE1C326AEB66Q33606014-F5106064-49F9-4167-BA59-2031EF0F1D06Q33755467-83C1E1E1-297E-4A3A-B4B5-1D1778150CE1Q33799041-00660F8C-2F99-4771-B7AF-470B9F1AD317Q33836466-EF0ADE2C-E9C1-4A40-AC07-F16D5A2EEF9BQ33859002-033C7395-A670-46B9-A66F-0208D9116F0FQ33910824-E9F0EC68-7793-48F2-9001-3E63B087AC6BQ34129343-C37279EF-11BE-4580-8447-768BDFC38456Q34207912-66A9AB49-0171-4F5D-A0A8-BDDC9718396FQ34301425-18941C0D-CBD4-4B61-97A6-0F5B59178E38Q34516361-F77B73A8-991D-4155-9712-E870B8411DA6Q34804784-18F31150-D563-4AEF-90E3-8E20513255D3Q35140267-9F5A1C0E-BA37-4383-BB64-78E09B124AB3Q35605415-E51B8A92-4F0E-44A3-8750-3C9B057AB68CQ35698518-208A5C15-6FF1-4590-A133-9AD29C70CDB7Q36268204-542199F1-0529-493B-875C-CCD0C7EAAD2EQ37133979-08E61362-4498-44A3-A0A4-563A32A56549Q37150635-B82F3DE1-E427-45D2-8C0E-738396959687Q37193604-B482F47A-26A7-4F3B-B81D-0067CF808164Q37454268-5B1294E0-59A7-435A-9314-0351A98F7858Q37965467-9B309782-8CEB-4A68-95BF-26BE31FA7E6BQ38209728-535F3B4D-01D7-4BF4-BF77-61714691BC36Q38383740-60470414-15A5-4FA7-9AB5-36072ECA435BQ38394534-5B7271D9-CF17-4E4B-8B14-8FD80463E8A6Q38617304-DBA50C33-FEAB-4F7E-9C69-6BC327A6FD55Q38620723-3C40E963-15B3-41EF-91ED-B68838903553Q38652387-C73C228B-7E51-4AE2-BFE5-DBECEB621B70Q38845915-957E64E4-440F-4BAA-B433-54BE636EA987Q38854126-FBEE05D0-0457-4EDF-9CA1-5B03DFDDB7DAQ39027273-A4FEB91A-B35A-4C4B-BA6F-30A1F0AB94E0Q39303542-91ED9D54-7622-4F3C-ABCB-A4975C4A1809Q40456452-EB29BD51-713F-478B-904F-20D10365011FQ41472011-140455B6-24AE-444F-8D06-0F06A5439602
P2860
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Regression methods for covaria ...... sored cost-effectiveness data.
@ast
Regression methods for covaria ...... sored cost-effectiveness data.
@en
type
label
Regression methods for covaria ...... sored cost-effectiveness data.
@ast
Regression methods for covaria ...... sored cost-effectiveness data.
@en
prefLabel
Regression methods for covaria ...... sored cost-effectiveness data.
@ast
Regression methods for covaria ...... sored cost-effectiveness data.
@en
P356
P1433
P1476
Regression methods for covaria ...... sored cost-effectiveness data.
@en
P2093
Andrew H Briggs
Andrew R Willan
P304
P356
10.1002/HEC.843
P407
P577
2004-05-01T00:00:00Z